<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0"><gtr:id>A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0</gtr:id><gtr:name>Gottfried Wilhelm Leibniz Universit?t Hannover (LUH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>School of Clinical Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0"><gtr:id>A29B5DC3-89DE-44FB-9AF8-4E00C562CDF0</gtr:id><gtr:name>Gottfried Wilhelm Leibniz Universit?t Hannover (LUH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D9A90A98-DFB8-4610-9BF7-964891121ED1"><gtr:id>D9A90A98-DFB8-4610-9BF7-964891121ED1</gtr:id><gtr:firstName>Matthew</gtr:firstName><gtr:surname>Brook</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/79D3C830-BA57-4226-BB02-1270FEC865CC"><gtr:id>79D3C830-BA57-4226-BB02-1270FEC865CC</gtr:id><gtr:firstName>Sander</gtr:firstName><gtr:surname>Granneman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F3B0A306-154C-44CD-AB85-EE369856007A"><gtr:id>F3B0A306-154C-44CD-AB85-EE369856007A</gtr:id><gtr:firstName>Nicola</gtr:firstName><gtr:otherNames>K.</gtr:otherNames><gtr:surname>Gray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3790EBA5-2C59-4BD3-983B-FECBD02A3B18"><gtr:id>3790EBA5-2C59-4BD3-983B-FECBD02A3B18</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Norman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4D171063-58D5-42C6-ABEE-D9F1B56A0E6F"><gtr:id>4D171063-58D5-42C6-ABEE-D9F1B56A0E6F</gtr:id><gtr:firstName>Guillermina</gtr:firstName><gtr:surname>Girardi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ003069%2F1"><gtr:id>D03E84F0-B3B2-475A-B660-F1E6923A5FBD</gtr:id><gtr:title>Poly(A)-binding proteins highlight the importance of regulated mRNA translation and stability in determining a functional materno-fetal interface</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J003069/1</gtr:grantReference><gtr:abstractText>The proteins that make up our cells are encoded by genes that serve as a genetic blueprint. The information stored in genes is expressed, or decoded, to produce proteins by a multi-step process known as gene expression, with one of the critical steps in this pathway being mRNA translation. In order to function properly, cells and organisms need to make proteins at the right time, place and in the correct amount. Thus it is critical that mRNA translation is carefully regulated, with improper control leading to a wide variety of diseases including cancer, metabolic, neurological and reproductive disorders.
Poly(A)-binding protein (PABP) 1 is a central regulator of multiple steps in the gene expression pathway, including mRNA translation. Mammals contain five genes belonging to the PABP family, two of which (PABP1 and PABP4) are produced in many cell types throughout the body. Although PABP1 has been extensively studied, little is known about the potential roles of PABP1, or other family members, in human health. However, we have recently found that an absence of PABP4 severely reduces mammalian fertility. This appears to be due to problems with the mother which lead to fetal death during the later stages of pregnancy. Interestingly, we see that live births are frequently small suggesting growth problems whilst in the womb (intrauterine growth restriction). Poor intrauterine growth predisposes human babies to health problems in adulthood including cardiovascular disease, stroke and type II diabetes. These important observations suggest that we have a unique opportunity to study the underlying causes of a spectrum of pregnancy complications including stillbirth, late miscarriage and intrauterine growth restriction. 
Nearly 3 million third-trimester stillbirths occur worldwide each year, with the UK having a higher rate (1 in 200) than almost every other high-income country. Research has shown that stillbirth can be caused by problems with the placenta, the umbilical cord or by infections, although in many cases the reasons why these problems arose is not understood. Moreover, up to 30% of stillbirths have no obvious cause, emphasising the need for research in this area. 
Our research aims to shed light on these issues by performing a detailed analysis of the functions and regulatory targets of PABP4, of which little is presently known, and by further investigating the cellular processes that fail to function normally in the absence of PABP4. Importantly, this will be paralleled by an investigation of PABP4 in human reproductive tissues. Taken together this work presents a unique opportunity to understand the pathways and mechanisms that lead to stillbirth and poor intrauterine growth. This forms the first step towards providing answers to couples that suffer such loss, and in the longer term may identify novel prognostic markers for pregnancy failure that could indicate the need for medical intervention. Ultimately it may offer avenues for therapeutic intervention prior to or during pregnancy.</gtr:abstractText><gtr:technicalSummary>The majority of mammalian mRNAs are now known to be regulated at the level of mRNA translation and/or stability, with dysregulation contributing to a wide range of diseases e.g. metabolic, neurological, and neoplastic disorders. However, the mechanisms of regulation are poorly understood. Poly(A)-binding protein (PABP) 1, the prototypical member of the PABP family, acts as a global determinant of mRNA translation and stability, regulates mRNA-specific translation and is required for miRNA-mediated repression and nonsense-mediated decay. However little is known about the biological roles of this central regulator of gene expression and other family members remain poorly characterised. As an important step toward determining the role of PABPs in human health, we are exploring their biological functions in vivo, focusing on the two widely expressed PABP proteins, PABP1 and PABP4. Intriguingly, PABP4 deficiency results in a specific defect in mammalian pregnancy, revealing a surprising role for maternally expressed PABP4 in fetal growth and viability during mid to late gestation. Thus, we will investigate the cellular and molecular roles of PABP4, define its mRNA targets and also determine the extent to which they overlap with PABP1 to test their functional relatedness. This will involve developmental, cellular, molecular and systems biology (in vivo; ex vivo; in vitro), patient sample analysis and several specialised techniques e.g. translational profiling using deep sequencing, proteomics, longitudinal analysis of pregnancy/placental function using ultrasound analysis/Doppler imaging. This will shed light on the role of misregulated translation/mRNA stability in intrauterine growth restriction, late miscarriage and stillbirth. Stillbirth affects almost 3 million couples annually and our work may provide a molecular diagnosis and be a first step towards pursuing potential therapeutic avenues, as our model relates not to fetal problems but to the biology of the mother.</gtr:technicalSummary><gtr:potentialImpactText>1. Academic community. The post-doctoral researchers will benefit from working on a multi-disciplinary program (e.g. post-transcriptional control, reproductive biology, systems biology) in a team composed of non-clinical and clinical scientists, and from methodology training that can be applied to other scientific questions in academic, clinical or industrial settings. The PI's laboratory also has a good track record of hosting and training scientists from other laboratories. The results of the proposal, including large datasets, will be of particular interest to, and serve as a resource for, those in the fields of mRNA translation/mRNA stability and reproductive biology. Indeed, the fundamental contribution of post-transcriptional control to almost every aspect of normal physiology, and increasingly in pathophysiology, makes our research relevant to diverse biological problems. Results will be disseminated to non-clinical, clinical and industrial researchers through publication, presentations, via datasets deposited in public databases and, if appropriate, via press releases coordinated through the University of Edinburgh press office (Pathways to Impact). Materials generated during the research will be made available (Academic Beneficiaries and Data Preservation and Sharing). 
2. Clinical and pharmacological impact. Stillbirth affects 1:200 births in the UK and the underlying mechanisms are either unknown or poorly understood, representing an unmet clinical need with large societal costs. In particular, the maternal defects (as in the case of PABP4 deficiency) that underlie stillbirth largely remain to be delineated but potentially offer greater scope for intervention than fetal defects. Consequently, in the longer term our results may benefit the clinical community working with families by providing a molecular diagnosis or by developing a marker for screening or novel therapeutic avenues. Our findings may also shed light on the mechanisms of intrauterine growth restriction (a related feature of PABP4 deficient mice), which predisposes babies to health problems in adulthood, including cardiovascular disease, stroke and type II diabetes.
Moreover, by providing insight into the molecular functions, interactomes and targets of the PABP family, our work may also indirectly impact other clinical areas. For instance, PABPs play key roles in host-viral interactions in a wide range of infections and mRNA-specific regulation by PABP-interacting proteins is critical in fertility (affecting 12-15% couples worldwide). Moreover, PABPs are important for nonsense-mediated decay (NMD) and miRNA-mediated regulation, which are associated with a wide variety of human diseases. Understanding fundamental molecular mechanisms is key to the future development of interventions, as demonstrated by clinical trials manipulating the efficiency of the NMD pathway. Our position in the College of Medicine and Veterinary Medicine and the work of the university technology transfer company, ERI, places us an ideal position to exploit clinical/commercial opportunities (see Pathways to Impact for details).
3. Industry: Translational control (mRNA-specific and global) is central to regulating protein synthesis rates and is linked to bulk cell growth in eukaryotes from yeast to humans. Thus understanding regulatory mechanisms can impact a variety of industrial applications including the production of recombinant proteins, and as a result people working within industry keep abreast of developments within this field via scientific literature and international conferences to which the PI's group regularly contributes.
4. Wider community and public engagement. The University has a press office which can disseminate information in a manner suitable to a wide audience, including patient charities. Moreover, the PI has a strong track record in public engagement and it is likely that this research will form the basis for a public lecture (Pathways to Impact and CV)</gtr:potentialImpactText><gtr:fund><gtr:end>2017-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1519696</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>ePABP phosphorylation</gtr:description><gtr:id>B1C2C74A-0B2A-488B-94CB-32A8D35DE74F</gtr:id><gtr:impact>Paper accepted for publication</gtr:impact><gtr:outcomeId>LeEjRvUmJHd-1</gtr:outcomeId><gtr:partnerContribution>Allowed us to understand the roles of phosphorylations that we had identified</gtr:partnerContribution><gtr:piContribution>Both teams contributed different aspects of reserach to provide a whole picture</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Reproductive Health</gtr:department><gtr:description>PABPs in Stillbiirth</gtr:description><gtr:id>8FE7DA1E-27B3-4A57-A1FC-07636107ED89</gtr:id><gtr:impact>Secured MRC Program grant</gtr:impact><gtr:outcomeId>ZXtnAAzu9VQ-1</gtr:outcomeId><gtr:partnerContribution>Allowed us to make progress into a new field</gtr:partnerContribution><gtr:piContribution>We developed the mouse model and brought knowledge of RNA-binding proteins</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Gottfried Wilhelm Leibniz Universit?t Hannover (LUH)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Neuronal Translational Control Centre for Molecular Neurobiology</gtr:department><gtr:description>ICP27 mechanism</gtr:description><gtr:id>213534CC-E7E8-4686-9DD8-B2C15DA90C6A</gtr:id><gtr:impact>BBSRC Project grant secured</gtr:impact><gtr:outcomeId>qagPzQCqWUB-1</gtr:outcomeId><gtr:piContribution>We have discovered a new mechanism of translational control</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Reproductive Health</gtr:department><gtr:description>Stillbirth</gtr:description><gtr:id>B32F11FE-C4B1-4AB3-9A60-1D579684F966</gtr:id><gtr:impact>Program grant funding awarded as PI</gtr:impact><gtr:outcomeId>jq2LarRhqQU-1</gtr:outcomeId><gtr:partnerContribution>Clinical collaborators and basic reserachers whom contributed to our successful program grant</gtr:partnerContribution><gtr:piContribution>Main reserachers in project</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F476E247-225C-457F-A739-C07B93E747A7</gtr:id><gtr:impact>Seminar was delivered, followed by lively question and answer session, then a drinks reception which gave more time for discussions and questions. Was attended by school children (late secondary), public, interested charities and patient groups.

This activity was filmed and is being used as a teaching resource for medical students on outreach activities.</gtr:impact><gtr:outcomeId>5460e3627a50e1.79639304</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parlimentary reception</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BC1EC439-5CF6-4F11-A4BB-47722B8B461D</gtr:id><gtr:impact>Invited to cross-party parlimentary science reception as member of the Bicohemical Society Council to meet politicans/jpurnalists and discuss informally challenges facing UK science.

Hopefully, we conveyed to the political and press attendees the importance of funding basic science. 

I have been invited to attend the event again this year,</gtr:impact><gtr:outcomeId>VjHW5B2LEDD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Keynote translation 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4D786FBF-BAD3-4A83-A435-B9FB6DC3B7B1</gtr:id><gtr:impact>Keynote talk</gtr:impact><gtr:outcomeId>56ddf87a4c82f4.33106220</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EMBL 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B6731D01-9CCB-42EE-853D-DA66D6994A09</gtr:id><gtr:impact>Questions and discussion, new international collaborations pending ... dependent on funding

Will write new grants</gtr:impact><gtr:outcomeId>546336490dd594.57109924</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RNA-UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>666AFABE-8294-4006-B7AF-D20CF3463CF1</gtr:id><gtr:impact>Discussions, questions,

Interest in our forthcoming publications</gtr:impact><gtr:outcomeId>546336abc92bf6.20613717</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>0</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC repsonsive mode</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P022065/1</gtr:fundingRef><gtr:id>2C205EA5-7DED-487A-A26F-FB594DF224A6</gtr:id><gtr:outcomeId>58c84b640e20a1.41677424</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>233660</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Clinical Training Fellowship (co-supervisor)</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>5CDEA41C-282C-40E5-8F44-7ED8EC3575CC</gtr:id><gtr:outcomeId>56ddfcb8684397.49123910</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CRH MReS program 2015</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3AC1986E-2FE9-415A-AA84-74B03A426E50</gtr:id><gtr:outcomeId>56ddf53dae5d07.99468111</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Tommys PhD studentship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Tommy's</gtr:fundingOrg><gtr:id>494707B7-97C3-470D-BA0B-19550D24516E</gtr:id><gtr:outcomeId>EoKGMFKrcJp</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PAGE bursary (student applied)</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>7CE4A213-784A-420C-8D18-9C4B97758A2B</gtr:id><gtr:outcomeId>pd6noR5WAKy</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC MReS program 2016</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9F957D62-C88E-43E3-934E-4093B8F84CB6</gtr:id><gtr:outcomeId>56ddf600915897.33783529</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>375</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SRF travel fund (Student applied)</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Society for Reproduction and Fertility</gtr:fundingOrg><gtr:id>CCC07FDF-2B71-4804-BB48-D4BB785ED59B</gtr:id><gtr:outcomeId>MSLT2cc4BMi</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council IMPC</gtr:description><gtr:end>2019-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/P02419X/1</gtr:fundingRef><gtr:id>63B454C6-72C7-4019-9C42-F77880272621</gtr:id><gtr:outcomeId>58c849a87ba3e9.18700021</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CRH MReS program 2013</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6098568B-28A5-46C5-AFBD-6A19C6C3C9B9</gtr:id><gtr:outcomeId>56ddf4dc1a38a3.03809490</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>185000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie</gtr:description><gtr:end>2019-04-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:fundingRef>MARS</gtr:fundingRef><gtr:id>F2CBCB2B-AA5C-4413-A044-36860A23DAB2</gtr:id><gtr:outcomeId>58c84ad18d3718.19862007</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3C7809FC-DC61-422A-906A-CE320F38B230</gtr:id><gtr:outcomeId>SF7MQYtTuLu</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Parlimentary reception on Science attendee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CEE02FB3-B984-4182-B4AF-148EB612A77C</gtr:id><gtr:outcomeId>ZtBFpp2u6GY</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D4CE28ED-CFD2-45DD-AD6D-283D90E63360</gtr:id><gtr:outcomeId>p6VW7haZGF7</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3D7B2EF2-6D67-47CB-8900-47E3C079A634</gtr:id><gtr:outcomeId>U9tVa1KSTew</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Biochemical Society</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2BA80DD6-C17A-4809-985D-64ECB220BB9C</gtr:id><gtr:outcomeId>Yes1qvuX6p4</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Science Select Committee Consultations</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D0B69A27-BB27-4471-BF3C-7A731E6F100F</gtr:id><gtr:outcomeId>eJeC2RxHJdg</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cross party general election debate on science</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5A1C805F-AF12-4805-9026-B9CF518A29A1</gtr:id><gtr:outcomeId>56d9aedd8f1616.23520623</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A series of unique antibodies have been generated against individual members of the PABP family</gtr:description><gtr:id>4B8B60F6-DA4D-42A6-9544-4AB4460F3320</gtr:id><gtr:impact>Allowed studies not previously possibe.</gtr:impact><gtr:outcomeId>rHdxaM4amFn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PABP-specific antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A mouse model of stillborth and interuterine growth retardation</gtr:description><gtr:id>2049546D-BBAB-42FD-891A-274FA1F9A011</gtr:id><gtr:impact>Secured program grant</gtr:impact><gtr:outcomeId>VhiQWeUdNyC</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>PABP4M</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>ED2D9152-DBAE-40A0-93CA-CB4626401B3D</gtr:id><gtr:title>Modulation of the cytoplasmic functions of mammalian post-transcriptional regulatory proteins by methylation and acetylation: a key layer of regulation waiting to be uncovered?</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a60fb60067773379dcf05d11033581f"><gtr:id>5a60fb60067773379dcf05d11033581f</gtr:id><gtr:otherNames>Blee TK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>56d9a69fd13c87.10213657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A30C1FE-9500-47CE-9903-902EF293CCB2</gtr:id><gtr:title>The multifunctional poly(A)-binding protein (PABP) 1 is subject to extensive dynamic post-translational modification, which molecular modelling suggests plays an important role in co-ordinating its activities.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>544f74634be630.39644736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC22A521-BAB0-456B-8BF2-D4B236B97934</gtr:id><gtr:title>Nuclear relocalisation of cytoplasmic poly(A)-binding proteins PABP1 and PABP4 in response to UV irradiation reveals mRNA-dependent export of metazoan PABPs.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3912a364780c8182e227f9fce6eacc"><gtr:id>4e3912a364780c8182e227f9fce6eacc</gtr:id><gtr:otherNames>Burgess HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_13491_21_21940797</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BFB7D7B-4288-45BC-BF52-30DB9C87BF36</gtr:id><gtr:title>Embryonic poly(A)-binding protein (ePAB) phosphorylation is required for Xenopus oocyte maturation.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fe8c1d4897aa3340d17438a801f8bf1"><gtr:id>4fe8c1d4897aa3340d17438a801f8bf1</gtr:id><gtr:otherNames>Friend K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_13491_21_22497250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97EF4FDC-62E6-4080-B266-4BFC37E9651D</gtr:id><gtr:title>A tail of translational regulation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af020d126456d05e975c5e00c444d0ae"><gtr:id>af020d126456d05e975c5e00c444d0ae</gtr:id><gtr:otherNames>Gray GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5aa7f7f186f312.58293787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF7046CB-0604-4124-A79B-95738C9201E8</gtr:id><gtr:title>The role of mammalian poly(A)-binding proteins in co-ordinating mRNA turnover.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_13491_21_22817748</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639D09F2-9BA9-460D-AF70-7D88C6AA3AD5</gtr:id><gtr:title>An integrated model for the nucleo-cytoplasmic transport of cytoplasmic poly(A)-binding proteins.</gtr:title><gtr:parentPublicationTitle>Communicative &amp; integrative biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3912a364780c8182e227f9fce6eacc"><gtr:id>4e3912a364780c8182e227f9fce6eacc</gtr:id><gtr:otherNames>Burgess HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1942-0889</gtr:issn><gtr:outcomeId>pm_13491_21_22896784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>124BF8A2-0515-4BBC-8CF0-BD06FDEFDE07</gtr:id><gtr:title>Poly(A)-binding proteins are functionally distinct and have essential roles during vertebrate development.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6c3d99a3715c5e41866fdf6c5c82f2e"><gtr:id>d6c3d99a3715c5e41866fdf6c5c82f2e</gtr:id><gtr:otherNames>Gorgoni B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Kr6viDbRcw4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>378002F0-A851-4A42-89F2-9D4D44F79783</gtr:id><gtr:title>Poly(A)-binding proteins are required for diverse biological processes in metazoans.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61c9b01397073965ad36d2de1b9f9e36"><gtr:id>61c9b01397073965ad36d2de1b9f9e36</gtr:id><gtr:otherNames>Smith RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>544f73bc8bfd11.84969599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D3FFB31-F6D3-4228-A560-C1ACEE0C4245</gtr:id><gtr:title>Viral and cellular mRNA-specific activators harness PABP and eIF4G to promote translation initiation downstream of cap binding.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b9f4b8811e11377496d7cde42c11c99"><gtr:id>5b9f4b8811e11377496d7cde42c11c99</gtr:id><gtr:otherNames>Smith RWP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a2fcc31788440.17629253</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44C2D8AA-F1CA-4B18-9E76-93A182875E85</gtr:id><gtr:title>Neutrophil-derived alpha defensins control inflammation by inhibiting macrophage mRNA translation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56d9a783938e25.01754855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D73FB7FF-CD1E-45D5-8B3C-4B6E8CDC9E9A</gtr:id><gtr:title>Two novel homozygous SLC2A9 mutations cause renal hypouricemia type 2.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89efa5c9a7c298f5d863d87435f42d23"><gtr:id>89efa5c9a7c298f5d863d87435f42d23</gtr:id><gtr:otherNames>Dinour D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>pm_13491_21_21810765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7431A3C-1529-4E36-BC97-81874833936B</gtr:id><gtr:title>DAZAP1, an RNA-binding protein required for development and spermatogenesis, can regulate mRNA translation.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61c9b01397073965ad36d2de1b9f9e36"><gtr:id>61c9b01397073965ad36d2de1b9f9e36</gtr:id><gtr:otherNames>Smith RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>jyVEZub9ViE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46E68A65-5078-4ED7-B8B4-ABFED72B5D0D</gtr:id><gtr:title>A molecular doorstop ensures a trickle through translational repression.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dacf07ad2d873f8c0b6488456a0642e"><gtr:id>0dacf07ad2d873f8c0b6488456a0642e</gtr:id><gtr:otherNames>Brook M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_13491_21_22464317</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J003069/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>